Navigation Links
Volcano Announces Installed Base Growth Milestone
Date:12/15/2009

he only multi-modality system capable of doing digital IVUS, high frequency rotational IVUS, VH® IVUS tissue characterization, ChromaFlo and FFR all on the same console today, and a path for additional modalities like OCT, Spectroscopy, Image Guided Therapy Balloons, and Forward Looking IVUS in the future. When hospitals purchase equipment today, they want to be sure it is capable of evolving with the needs of their physicians, and many of them see that vision in Volcano's pipeline."

Precision guidance products such as FFR and IVUS have experienced an impressive increase in adoption over the past year. Despite a minor increase in overall PCI procedure volume in the U.S., Volcano IVUS catheter unit sales are up 19% and Volcano FFR wires are up 73% year-to-date as compared to the same period a year ago. These tools are being increasingly relied upon by physicians who continue to look for ways to improve on current drug-eluting stent (DES) outcomes, especially in more complex lesions and in patients with multi-vessel disease.

Joe Burnett, Vice President of Marketing at Volcano commented, "FFR is a particular focus for Volcano, and the momentum has continued after the publication of new updates to the PCI guidelines from the American College of Cardiology and the American Heart Association earlier this week. These two prestigious societies 'upgraded' the level of evidence in support of FFR from level B to level A largely based on the strong FAME study data. We look to become a leader in the FFR market the same way we have in IVUS, by having the best portfolio of FFR wires and using accelerated installed base placements to fuel market share growth. It took us over fifteen years to place 800 earlier generation FFR systems worldwide. In the last 12 months, we have enabled FFR on over 1200 s5 and s5i systems through either upgrades or new placements, more than doubling the installed base of FFR capable systems. This is the power of our platfor
'/>"/>

SOURCE Volcano Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging
2. Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
3. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
4. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
5. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
6. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
7. West Announces First Quarter 2010 Dividend
8. Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations
9. Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
10. Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability
11. Manchester Announces Availability of Chenodal(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... NEW YORK , March 27, 2015 ... ), the leading source of health information, ... on the new National Action Plan ... interview, President Obama emphasized the urgency and ... impact on national and global health.    ...
(Date:3/26/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... therapies for cardiovascular disease and overall health, announced that ... of the Corporation (the "Common Shares"). The Common Shares ... 5 th , 2014 to March 4 th , ... on or before April 1, 2015. Interest on the ...
(Date:3/26/2015)... "Whether it,s our family, our friends, all ... In a single sentence, Dr. Anthony Coyle , ... Centers for Therapeutic Innovation (CTI), sums up ... America,s biopharmaceutical companies. CTI,s unique model ... foundations and the National Institutes of Health (NIH) to ...
Breaking Medicine Technology:Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2
... , BOZEMAN, Mont., Sept 8 ... its third human clinical trial of its norovirus vaccine. ... with LigoCyte,s investigational, nasally-delivered, dry powder vaccine in healthy adults. ... of norovirus infection by including a live virus challenge of ...
... , MORGANTON, W.Va., Sept. 4 People with chronic ... and depression than people treated conventionally for back pain, a West ... , , The three-year, $400,000 study, published in ... pain and improved function in the group that did yoga postures ...
Cached Medicine Technology:LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 2LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 3Yoga Benefits Back-Pain Patients 2
(Date:3/29/2015)... (PRWEB) March 29, 2015 The ... ( http://www.testosteronelawsuithub.com/ ) pending in the U.S. District ... litigation’s next Case Management Conference for April 21st ... meeting will address the progress of product liability ... experienced heart attacks, strokes and other cardiovascular complications ...
(Date:3/29/2015)... March 29, 2015 North American Seminars ... PT Online Continuing Education Courses . , ... of CME - TPTA, approval # 56399TX      , ... of the shoulder complex - 10.5 hours - Texas ... , Examination and Treatment of the SI Joint - ...
(Date:3/28/2015)... March 28, 2015 Could genetic code ... new study by researchers at the Harvard ... with the support of the Coffee and Caffeine Genetics ... Psychiatry this past fall, the study—one of several recent ... genomic data from more than 120,000 regular coffee drinkers ...
(Date:3/28/2015)... York, New York (PRWEB) March 28, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) involving devices manufactured by C.R. Bard, ... litigation underway in U.S. District Court, Southern District ... S. Grand, is serving on the Plaintiffs’ Steering ... 24th, the Court has granted certain defendants named ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 An article ... problem which could prove critical to organizations that deal ... a critical aspect of data security, is worsening . ... data security report, every major category out of the ... penetration testing. “With all the craziness that has gone ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 3Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4
... pet food continues to takes it toll in the US. ... //was placed under quarantine following detection of the industrial chemical ... testing was under way to determine if the chemical was ... 3, according to the California Department of Food and Agriculture ...
... Network is very near to achieving one of today’s Science ... health conditions.// ,As well as from the UGR, ... and Reus also took part in this study, concluding that ... small amounts by human beings and present in many types ...
... commonest medical disorder in pregnancy, adversely affecting maternal ... at control and treatment of anemia during pregnancy, ... the majority of women present late. ... have consequences that extend over generations. Girls born ...
... Dev has launched a seven-day camp in this Taj Mahal ... other licentious activities.// ,Ram Dev, who enjoys wide following ... education being given to the young. ,'A balanced ... he said. ,Later speaking to journalists, Ram Dev ...
... may have the most significant impact in reducing ... Americans and Caucasians, according to a new study. ... CANCER, a peer-reviewed journal of the American Cancer ... demonstrated that when socioeconomic factors and treatment utilization ...
... concerned citizens. Delhi, burning under the scorching summer sun, heralded ... issues that are pricking our fragile ecosystem. ,'We ... of Toxics Link, an environmental NGO. 'The issue of stopping ... needs to be addressed immediately and a day such as ...
Cached Medicine News:Health News:Pigs Quarantined in US Farm Following Melamine Contamination 2Health News:High Melatonin can Help Delay Ageing 2Health News:Social Factors Not Genetics Drive Racial Disparities in Colorectal Cancer Survival 2Health News:Earth Day Celebrated With Hopes of a Greener Tomorrow 2
This set is designed to introduce the low vision practitioner to the Keeler telescopic system....
... up to 20 tilting ... in the vertical, horizontal ... the option to offset ... transillumination., ,Filters include Cobalt ...
An easy to use uncomplicated ophthalmoscope....
With a high lens and filter range this ophthalmoscope is ideal for the Primary Care Specialist...
Medicine Products: